NCT01110590 - Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions

Erectile Dysfunction

Interventions

DRUG

BAY60-4552 + Vardenafil

Total dose given over 14 days: 5.25 mg BAY60-4552 + 140 mg Vardenafil

DRUG

BAY60-4552 + Vardenafil

Total dose given over 14 days: 21.0 mg BAY60-4552 + 140 mg Vardenafil

DRUG

BAY60-4552 + Vardenafil

Total dose given over 14 days: 21.0 mg BAY60-4552 + 280 mg Vardenafil

DRUG

Placebo

Trial Locations (1)

Mönchengladbach